美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

BridgeBio Oncology Therapeutics, Inc

11.95

+0.97008.83%

盤後：12.300.3500+2.93%19:19 EDT

成交量：16.40萬

成交額：188.82萬

市值：9.46億

市盈率：-0.04

高：11.96

開：11.01

低：11.01

收：10.98

52周最高：13.18

52周最低：8.50

股本：7,919.67萬

流通股本：4,460.40萬

量比：0.53

換手率：0.37%

股息：- -

股息率：- -

每股收益(TTM):-268.5581

每股收益(LYR):-511.8002

淨資產收益率：--

總資產收益率：--

市淨率：-4.16

市盈率(LYR):-0.02

資料載入中...

總覽公司新聞公告

公司資料

公司名字：

BridgeBio Oncology Therapeutics, Inc

交易所：

NASDAQ

成立時間：

2016

員工人數：

- -

公司地址：

256 E. Grand Avenue,Suite 104,South San Francisco,California,United States

官網：

- -

郵編：

94080

電話：

傳真：

- -

簡介：

BridgeBio Oncology Therapeutics, Inc.於2021年6月15日作為開曼群島豁免公司註冊成立。自2025年8月12日起，該公司完成了先前宣布的業務合併，合併后的公司註冊地位於特拉華州。BBOT是一家臨床階段的生物技術公司，其使命是在RAS和PI3K α這兩種最常發生突變的癌基因的驅動下改變癌症患者的生活。

董事

名稱

職位

Eli Wallace

Chief Executive Officer and Director

Frank P. McCormick

Director and Chairman of the board

Bihua Chen

Director

Jake Bauer

Director

Michelle Doig

Director

Neil Kumar

Director

Praveen Tipirneni

Director

Raymond Kelleher

Director

股東

名稱

職位

Eli Wallace

Chief Executive Officer and Director

Uneek Mehra

Chief Financial Officer

Pedro J. Beltran

Chief Scientific Officer

Yong Ben

Chief Medical and Development Officer

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BBOT/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BBOT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBOT\",,,,,undefined,":{"symbol":"BBOT","market":"US","secType":"STK","nameCN":"BridgeBio Oncology Therapeutics, Inc","latestPrice":11.95,"timestamp":1760558400000,"preClose":10.98,"halted":0,"volume":164018,"hourTrading":{"tag":"盘后","latestPrice":12.3,"preClose":11.95,"latestTime":"19:19 EDT","volume":2206,"amount":26456.97,"timestamp":1760570355228},"delay":0,"floatShares":44603977,"shares":79196710,"eps":-268.55814,"marketStatus":"已收盤","change":0.97,"latestTime":"10-15 16:00:00 EDT","open":11.01,"high":11.96,"low":11.005,"amount":1888184.401008,"amplitude":0.086976,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-268.55814,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1760601600000},"marketStatusCode":5,"adr":0,"listingDate":1707454800000,"exchange":"NASDAQ","adjPreClose":10.98,"preHourTrading":{"tag":"盘前","latestPrice":10.98,"preClose":10.98,"latestTime":"08:00 EDT","volume":13,"amount":142.74,"timestamp":1760529610191},"postHourTrading":{"tag":"盘后","latestPrice":12.3,"preClose":11.95,"latestTime":"19:19 EDT","volume":2206,"amount":26456.97,"timestamp":1760570355228},"volumeRatio":0.528797},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBOT\",,,,,undefined,":{"symbol":"BBOT","floatShares":44603977,"roa":"--","roe":"--","lyrEps":-511.800172,"volumeRatio":0.528797,"shares":79196710,"dividePrice":0,"high":11.96,"amplitude":0.086976,"preClose":10.98,"low":11.005,"week52Low":8.5,"pbRate":"-4.16","week52High":13.18,"institutionHeld":0,"latestPrice":11.95,"eps":-268.55814,"divideRate":0,"volume":164018,"delay":0,"ttmEps":-268.55814,"open":11.01,"prevYearClose":10.5,"prevWeekClose":11.82,"prevMonthClose":11.58,"prevQuarterClose":11.58,"fiveDayClose":12.025,"twentyDayClose":10.79,"sixtyDayClose":10.75},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBOT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-01","symbol":"BBOT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1754020800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-05-15","symbol":"BBOT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-11-14","symbol":"BBOT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBOT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBOT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":6,"updateTime":1758168000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BBOT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BBOT","date":"2025-10-14","current":-0.044497,"percent":0.512821,"low":-11.944957,"twenty":-11.205617,"median":-10.377032,"eighty":-9.58363,"high":-8.733947,"avg":-10.394406,"sd":0.839558,"marketCap":907594296},"quantilePoints":[{"date":"2025-08-22","current":-9.544109,"twenty":-10.820609,"median":-9.81087,"eighty":-9.532253,"marketCap":835109579},{"date":"2025-08-29","current":-9.336629,"twenty":-9.787158,"median":-9.514469,"eighty":-9.277349,"marketCap":816955023},{"date":"2025-09-05","current":-9.959071,"twenty":-9.864223,"median":-9.514469,"eighty":-9.247708,"marketCap":871418691},{"date":"2025-09-12","current":-10.047991,"twenty":-10.065775,"median":-9.65773,"eighty":-9.388005,"marketCap":879199215},{"date":"2025-09-19","current":-10.690193,"twenty":-10.20212,"median":-9.78123,"eighty":-9.467045,"marketCap":935391888},{"date":"2025-09-26","current":-11.678196,"twenty":-11.017222,"median":-9.944251,"eighty":-9.487793,"marketCap":1021842155},{"date":"2025-10-03","current":-11.259509,"twenty":-11.190123,"median":-10.077631,"eighty":-9.526325,"marketCap":985207072},{"date":"2025-10-10","current":-11.196152,"twenty":-11.224546,"median":-10.323455,"eighty":-9.563869,"marketCap":979663302},{"date":"2025-10-14","current":-10.372506,"twenty":-11.205617,"median":-10.377032,"eighty":-9.58363,"marketCap":907594296}],"updateTime":1760566718724},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":623256762,"yearFounded":2016,"address":"256 E. Grand Avenue,Suite 104,South San Francisco,California,United States","zipCode":"94080","officePhone":"650 405 4770"},"stockCompanyDetail":{"stockEarnings":[{"period":"1week","weight":-0.1007},{"period":"1month","weight":0.0568},{"period":"3month","weight":0.0281},{"period":"6month","weight":0.0195},{"period":"1year","weight":0.0457},{"period":"ytd","weight":0.0457}],"compareEarnings":[{"period":"1week","weight":-0.0103},{"period":"1month","weight":0.0073},{"period":"3month","weight":0.0609},{"period":"6month","weight":0.258},{"period":"1year","weight":0.1333},{"period":"ytd","weight":0.1299}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"BridgeBio Oncology Therapeutics, Inc.於2021年6月15日作為開曼群島豁免公司註冊成立。自2025年8月12日起，該公司完成了先前宣布的業務合併，合併后的公司註冊地位於特拉華州。BBOT是一家臨床階段的生物技術公司，其使命是在RAS和PI3K α這兩種最常發生突變的癌基因的驅動下改變癌症患者的生活。","exchange":"NASDAQ","name":"BridgeBio Oncology Therapeutics, Inc","nameEN":"BridgeBio Oncology Therapeutics, Inc"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"BBOT\",market:\"US\",,,undefined,":{"directors":[{"name":"Eli Wallace","position":"Chief Executive Officer and Director"},{"name":"Frank P. McCormick","position":"Director and Chairman of the board"},{"name":"Bihua Chen","position":"Director"},{"name":"Jake Bauer","position":"Director"},{"name":"Michelle Doig","position":"Director"},{"name":"Neil Kumar","position":"Director"},{"name":"Praveen Tipirneni","position":"Director"},{"name":"Raymond Kelleher","position":"Director"}],"executives":[{"name":"Eli Wallace","position":"Chief Executive Officer and Director"},{"name":"Uneek Mehra","position":"Chief Financial Officer"},{"name":"Pedro J. Beltran","position":"Chief Scientific Officer"},{"name":"Yong Ben","position":"Chief Medical and Development Officer"}]}}}